A family visited a bat cave in Costa Rica. They were then infected with a fungal disease.
A family visited a bat cave in Costa Rica. They were then infected with a fungal disease.
Show Caption
Hide Caption
Zoonotic diseases, like monkeypox and COVID-19, are on the rise
From monkeypox to COVID-19, zoonotic disease outbreaks are on the rise. Here's how viruses spread from animals to humans.
Just the FAQs, USA TODAY
A bat cave in Costa Rica is likely the reason a family caught a fungal lung disease known as histoplasmosis.
In December of last year, a family of 13 visited Arenal and Manuel Antonio, Costa Rica, according to the CDC. While there, 12 of the 13 people on the trip visited the Venado Caves, a popular tourist attraction in the Alajuela Province of San Carlos, Costa Rica, according to a report published by the CDC.
Each person who visited the cave "became mildly or moderately ill" with the fungal lung infection when they returned to the U.S. to their homes in Georgia, Texas, and Washington.
The CDC, along with the Georgia Department of Public Health, Texas Department of State Health Services, and the Washington State Department of Health, launched a multi-state investigation in January into the cases after a physician in Georgia notified the CDC of suspected cases of histoplasmosis.
All of the family members reported seeing bats and stated that they had touched bat droppings while crawling through the cave and "squeezing through tight spaces."
Raccoons, foxes, bats ... oh my! Know the animals most prone to rabies and protect yourself.
What is histoplasmosis?
Histoplasmosis is a fungal disease commonly linked to bats and bird droppings, according to the Mayo Clinic.
"The fungus is commonly found growing in damp soil that's rich in organic material," like droppings from the animals mentioned above.
It is also commonly found in the following places, according to the Mayo Clinic:
Chicken and pigeon coops
Old barns
Caves
Parks
How does histoplasmosis spread?
People become infected with the fungal disease when they breathe in the spores of the fungus Histoplasma after the soil in which it resides is disturbed, according to the Los Angeles County Department of Public Health.
People are just as likely to contract it from bat droppings as they are from bird droppings.
The fungal disease does not spread from person to person, according to the CDC.
What are the symptoms of histoplasmosis?
Usually, when people breathe in the spores, they do not get sick, according to the CDC.
But those who do have it can face mild to life-threatening symptoms of pneumonia. The fungal infection is often misdiagnosed or diagnosed late because it can be mistaken for common pneumonia caused by bacteria and viruses.
People infected with Histoplasmosis can feel the following, according to the CDC:
Fever
Cough
Extreme tiredness
Chills
Headache
Chest pain
People with weakened immune systems could also develop a long-term lung infection, which, on rare cases, could spread to the brain and spinal cord.
Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn,X, Instagram and TikTok: @juliamariegz, or email her at jgomez@gannett.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
A new COVID-19 variant, vaccine changes: What to know in 2025
A new COVID-19 variant, vaccine changes: What to know in 2025 Show Caption Hide Caption RFK Jr. says COVID-19 vaccine no longer recommended for some The COVID-19 vaccine is no longer recommended for healthy children and pregnant women, HHS Secretary Robert F. Kennedy Jr. says. Like it or not, COVID-19 is still a public health issue five years after the start of the pandemic flipped the nation, and the world, on its head. Changing vaccination guidelines, ever-evolving variants and strains, threats to health insurance and more mean COVID is still very much a regular conversation on the lips of lawmakers, regulators and the general public. More than 40,000 positive tests were reported by the Centers for Disease Control and Prevention in May, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Here is a brief recap of the status of COVID cases, variants and vaccines in the U.S. as of June 4, 2025. Where do COVID cases currently stand in the US? According to the most recent data on the CDC's COVID Data Tracker dashboard, there were 735 confirmed COVID-19 deaths in May 2025 as of May 24. In the four weeks leading up to May 24, 3% of 1,344,681 COVID tests administered nationwide were positive. New NB.1.8.1 COVID variant In January, a new COVID-19 variant known as NB.1.8.1 was first detected in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO). As of May 27, less than 20 cases of NB.1.8.1 had been reported in the U.S., a CDC spokesperson told USA TODAY. This figure is too low to be added to the CDC's COVID Data Tracker dashboard, the spokesperson added, though they did not clarify the threshold for adding new variants to the dashboard. New COVID variant in China: Here's what to know about NB.1.8.1 NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY. For comparison, LP.8.1 made up 70% of reported COVID-19 cases in the U.S. between April 26 and May 10, as reported by the CDC. Verma said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. Vaccine back-and-forth: Who can get it and will there be new boosters? Health and Human Services Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. RFK changes vaccine recommendations: Want a COVID vaccine? It could cost you $200. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. RFK Jr. is a vaccine skeptic known for making false claims about vaccination and other medical practices. Under his leadership and the Trump administration, the FDA canceled the advisory meeting of independent experts who usually gather to formulate new flu shots annually and nixed a contract with Moderna to develop a bird flu vaccine amid the spread. He also pushed false claims about MMR vaccines as measles, previously eradicated in the U.S., began erupting in states across the country, causing the first death in a decade. It is not yet known how accessible the COVID-19 vaccine will be moving forward. Contributing: Karen Weintraub, Sudiksha Kochi, USA TODAY; Reuters
Medscape
2 hours ago
- Medscape
Novel Gene Risk Score Predicts Outcomes After RYGB Surgery
A novel gene risk score, informed by machine learning, predicted weight-loss outcomes after Roux-en-Y gastric bypass (RYGB) surgery, a new analysis showed. The findings suggested that the MyPhenome test (Phenomix Sciences) can help clinicians identify the patients most likely to benefit from bariatric procedures and at a greater risk for long-term weight regain after surgery. 'Patients with both a high genetic risk score and rare mutations in the leptin-melanocortin pathway (LMP) had significantly worse outcomes, maintaining only 4.9% total body weight loss [TBWL] over 15 years compared to up to 24.8% in other genetic groups,' Phenomix Sciences Co-founder Andres Acosta, MD, PhD, told Medscape Medical News . The study included details on the score's development and predictive capability. 'More Precise Bariatric Care' The researchers recently developed a machine learning-assisted gene risk score for calories to satiation (CTSGRS), which mainly involves genes in the LMP. To assess the role of the score with or without LMP gene variants on weight loss and weight recurrence after RYGB, they identified 707 patients with a history of bariatric procedures from the Mayo Clinic Biobank. Patients with duodenal switch, revisional procedures, or who used antiobesity medications or became pregnant during follow-up were excluded. To make predictions for 442 of the patients, the team first collected anthropometric data up to 15 years after RYGB. Then they used a two-step approach: Assessing for monogenic variants in the LMP and defining participants as carriers (LMP+) or noncarriers (LMP-). Then they defined the gene risk score (CTSGRS+ or CTSGRS-). The result was four groups: LMP+/CTSGRS+, LMP+/CTSGRS-, LMP-/CTSGRS+, and LMP-/CTSGRS-. Multiple regression analysis was used to analyze TBWL percentage (TBWL%) between the groups at different timepoints, adjusting for baseline weight, age, and gender. At the 10-year follow-up, the LMP+/CTSGRS+ group demonstrated a significantly higher weight recurrence (regain) of TBW% compared to the other groups. At 15 years post-RYGB, the mean TBWL% for LMP+/CTSGRS+ was -4.9 vs -20.3 for LMP+/CTSGRS-, -18.0 for LMP-/CTSGRS+, and -24.8 for LMP-/CTSGRS-. Further analyses showed that the LMP+/CTSGRS+ group had significantly less weight loss than LMP+/CTSGRS- and LMP-/CTSGRS- groups. Based on the findings, the authors wrote, 'Genotyping patients could improve the implementation of individualized weight-loss interventions, enhance weight-loss outcomes, and/or may explain one of the etiological factors associated with weight recurrence after RYGB.' Acosta noted, 'We're actively expanding our research to include more diverse populations by age, sex, and race. This includes ongoing analysis to understand whether certain demographic or physiological characteristics affect how the test performs, particularly in the context of bariatric surgery.' The team also is investigating the benefits of phenotyping for obesity comorbidities such as heart disease and diabetes, he said, and exploring whether early interventions in high-risk patients can prevent long-term weight regain and improve outcomes. In addition, Acosta said, the team recently launched 'the first prospective, placebo-controlled clinical trial using the MyPhenome test to predict response to semaglutide.' That study is based on earlier findings showing that patients identified with a Hungry Gut phenotype lost nearly twice as much weight on semaglutide compared with those who tested negative. Overall, he concluded, 'These findings open the door to more precise bariatric care. When we understand a patient's biological drivers of obesity, we can make better decisions about the right procedure, follow-up, and long-term support. This moves us away from a one-size-fits-all model to care rooted in each patient's unique biology.' Potentially Paradigm-Shifting Onur Kutlu, MD, associate professor of surgery and director of the Metabolic Surgery and Metabolic Health Program at the Miller School of Medicine, University of Miami, Miami, commented on the study for Medscape Medical News . 'By integrating polygenic risk scores into predictive models, the authors offer an innovative method for identifying patients at elevated risk for weight regain following RYGB.' 'Their findings support the hypothesis that genetic predisposition — particularly involving energy homeostasis pathways — may underlie differential postoperative trajectories,' he said. 'This approach has the potential to shift the paradigm from reactive to proactive management of weight recurrence.' Because current options for treat weight regain are 'suboptimal,' he said, 'prevention becomes paramount. Preoperative identification of high-risk individuals could inform surgical decision-making, enable earlier interventions, and facilitate personalized postoperative monitoring and support.' 'If validated in larger, prospective cohorts, genetic risk stratification could enhance the precision of bariatric care and improve long-term outcomes,' he added. 'Future studies should aim to validate these genetic models across diverse populations and explore how integration of behavioral, psychological, and genetic data may further refine patient selection and care pathways.' The study presented at Digestive Disease Week (DDW) 2025 was funded by Mayo Clinic and Phenomix Sciences. Gila Therapeutics and Phenomix Sciences licensed Acosta's research technologies from the University of Florida and Mayo Clinic. Acosta declared receiving consultant fees in the past 5 years from Rhythm Pharmaceuticals, Gila Therapeutics, Amgen, General Mills, BI, Currax, Nestle, Phenomix Sciences, Bausch Health, and RareDiseases, as well as funding support from the National Institutes of Health, Vivus Pharmaceuticals, Novo Nordisk, Apollo Endosurgery, Satiogen Pharmaceuticals, Spatz Medical, and Rhythm Pharmaceuticals. Kutlu declared having no conflicts of interest.
Fast Company
3 hours ago
- Fast Company
Salmonella outbreak: Recalled eggs sold at Walmart, Safeway, and elsewhere sicken people in 7 states
A significant recall of 1.7 million dozen eggs is underway. The eggs were believed to be the source of a salmonella outbreak that has sickened dozens of people across seven states and so far led to 21 people being hospitalized. They were distributed to several major retailers, including Walmart and Safeway. Here's what you need to know about the recall and outbreak. Shell eggs recalled due to salmonella fears On June 6, the August Egg Company of Hilmar, California, issued a voluntary recall of 1.7 million dozen eggs produced at its facilities. The company initiated the recall after it discovered that the eggs are feared to have been contaminated with salmonella, a potentially deadly bacterium. On the same day, the U.S. Food and Drug Administration (FDA) published August Egg Company's recall notice on its website, while the U.S. Centers for Disease Control and Prevention (CDC) announced an investigation into a multistate outbreak of salmonella linked to eggs. Dozens sickened and hospitalized across 7 states The CDC's investigation has found that eggs produced by August Egg Company are linked to dozens of cases of people becoming ill after consuming them. The agency's latest data shows that there are so far 79 cases linked to the August Egg Company's recalled products. Of those cases, 21 have resulted in hospitalizations. Thankfully, no deaths have been reported so far. The cases are spread across seven states: Arizona, California, Kentucky, Nebraska, New Jersey, Nevada, and Washington. Of those states, California has the most number of cases, at 63, followed by Washington and Nevada, with four cases each. Arizona has had three cases, Nebraska and New Jersey two cases, and Kentucky has one. However, many people who become sick with salmonella see their symptoms resolve without contacting a health professional, so the actual number of cases could be higher. When and where were the eggs distributed? According to the notice posted on the FDA's website, the recalled eggs were distributed between February and May. The retail locations that received the eggs include: Walmart Save Mart FoodMaxx Lucky Smart & Final Safeway Raleys Food 4 Less Ralphs The eggs were distributed between February 3 and May 15, 2025, to Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs locations in California and Nevada. Those eggs had sell-by dates ranging from March 4 to June 4, 2025. The eggs were also distributed between February 3 through May 6, 2025, to Walmart stores in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois. Those eggs had sell-by dates ranging from March 4 to June 19, 2025. What eggs are included in the recall? Over two dozen egg products packaged under multiple brands are included in the recall. The recall notice states that the eggs were packaged in fiber or plastic cartons and have a plant code number P-6562 or CA5330 with the Julian Dates between 32 to 126. Photographs of the cartons can be found here. The item names of the egg products included in the recall, along with their plant number and carton UPC are: Item Name Plant Number Carton UPC Clover Organic Large Brown 12 eggs P-6562 or CA-5330 070852010427 First Street Cage Free Large Brown Loose 1 case=150 eggs P-6562 or CA-5330 041512039638 Nulaid Medium Brown Cage Free 12 eggs P-6562 or CA-5330 071230021042 Nulaid Jumbo Brown Cage Free 12 eggs P-6562 or CA-5330 071230021011 O Organics Cage Free Large Brown 6 eggs P-6562 or CA-5330 079893401522 O Organics Large Brown 12 eggs P-6562 or CA-5330 079893401508 O Organics Large Brown 18 eggs P-6562 or CA-5330 079893401546 Marketside Organic Large Cage Free Brown 12 eggs P-6562 or CA-5330 681131122771 Marketside Organic Large Cage Free Brown 18 eggs P-6562 or CA-5330 681131122801 Marketside Large Cage Free Brown 12 eggs P-6562 or CA-5330 681131122764 Marketside Large Cage Free Brown 18 eggs P-6562 or CA-5330 681131122795 Raley's Large Cage Free Brown 12 eggs P-6562 or CA-5330 046567033310 Raley's Large Cage Free Brown 18 eggs P-6562 or CA-5330 046567040325 Raley's Organic Large Cage Free Brown 12 eggs P-6562 or CA-5330 046567028798 Raley's Organic Large Cage Free Brown 18 eggs P-6562 or CA-5330 046567040295 Simple Truth Medium Brown Cage Free 18 eggs P-6562 or CA-5330 011110099327 Simple Truth Large Brown Cage Free 18 eggs P-6562 or CA-5330 011110873743 Sun Harvest Organic Cage Free Large Brown 12 eggs P-6562 or CA-5330 041512131950 Sun Harvest Organic Cage Free Large Brown 18 eggs P-6562 or CA-5330 041512145162 Sunnyside Large Brown Cage Free 12 eggs P-6562 or CA-5330 717544211747 Sunnyside Large Brown Cage Free 18 eggs P-6562 or CA-5330 717544211754 Sunnyside Organic Cage Free Large Brown 12 eggs P-6562 or CA-5330 717544201441 Sunnyside Organic Cage Free Large Brown 18 eggs P-6562 or CA-5330 717544211761 Loose Small Brown Cage Free-1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA Loose Medium Brown Cage Free -1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA Loose Medium Brown Organic -1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA Loose Large Brown Organic-1 box= 6 flats (1 flat= 30 eggs) P-6562 or CA-5330 NA Loose Jumbo Brown Cage Free -1 box=5 flats(1 flat=20 eggs) P-6562 or CA-5330 NA Loose Jumbo Brown Organic -1 box=5 flats(1 flat=20 eggs) P-6562 or CA-5330 NA What is Salmonella? Salmonella is a potentially deadly bacterium that is usually contracted after eating contaminated foods. The CDC says that typical symptoms of a salmonella infection include diarrhea, fever, and stomach cramps, which typically present between six hours and six days after exposure to the bacteria. Typical salmonella infections last between four and seven days, and most people recover without treatment. However, salmonella infections can also cause severe illness in individuals, especially those who are younger than five, older than 65, or have weakened immune systems. What should I do if I have the recalled eggs? According to the CDC, if you have the recalled eggs in your possession, you should not consume them. Instead, you should throw the eggs out or return them to their place of purchase for a refund. You should also sanitize all surfaces that may have come into contact with the eggs.
